| Literature DB >> 33962683 |
Xiao-Li Wang1,2,3, Xin Lin4, Peng Yang1,2, Zun-You Wu5, Gang Li1, Jennifer M McGoogan5, Zeng-Tao Jiao6, Xin-Jun He6, Si-Qi Li7, Hong-Hao Shi4, Jing-Yuan Wang8, Sheng-Jie Lai9,10, Chun Huang11, Quan-Yi Wang12,13.
Abstract
BACKGROUND: A local coronavirus disease 2019 (COVID-19) case confirmed on June 11, 2020 triggered an outbreak in Beijing, China after 56 consecutive days without a newly confirmed case. Non-pharmaceutical interventions (NPIs) were used to contain the source in Xinfadi (XFD) market. To rapidly control the outbreak, both traditional and newly introduced NPIs including large-scale management of high-risk populations and expanded severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) PCR-based screening in the general population were conducted in Beijing. We aimed to assess the effectiveness of the response to the COVID-19 outbreak in Beijing's XFD market and inform future response efforts of resurgence across regions.Entities:
Keywords: Beijing; COVID-19; Nonpharmaceutical intervention; Public health; SARS-CoV-2
Mesh:
Year: 2021 PMID: 33962683 PMCID: PMC8103671 DOI: 10.1186/s40249-021-00843-2
Source DB: PubMed Journal: Infect Dis Poverty ISSN: 2049-9957 Impact factor: 4.520
Group of key population and attack rate of each group
| Group | Exposed populations | Quarantine protocol | Tracing techniques | Risk level | Total no | No. of cases | Attack rate (%) |
|---|---|---|---|---|---|---|---|
| 1 | Workers at the XFD market | Centralized quarantine | Onsite | High | 3311 | 169 | 5.10 |
| 1.1 | Workers at the BMTH | Centralized quarantine | Onsite | High | 838 | 119 | 14.20 |
| 1.2 | Workers at the XFD market other than BMTH | Centralized quarantine | Onsite | High | 2473 | 50 | 2.02 |
| 2 | Visitors to the XFD market on June 12th | Centralized quarantine | Onsite | Medium | 7689 | 8 | 0.10 |
| 2.1 | Visitors to the BMTH market | Centralized quarantine | Onsite | Medium | 1078 | 8 | 0.74 |
| 2.2 | Visitors to the XFD market other than BMTH | Centralized quarantine | Onsite | Medium | 6611 | 0 | 0 |
| 3 | Visitors to XFD between May 30th and June 11th | Home quarantine | Big data | Low | 535 000 | 95 | 0.02 |
| 3.1 | Visitors to the BMTH market | Home quarantine | Big data | Low | 75 000 | 64 | 0.09 |
| 3.2 | Visitors to the XFD market other than BMTH | Home quarantine | Big data | Low | 460 000 | 31 | 0.007 |
BMTH Beef and Mutton Trading Hall, XFD Xinfadi
Epidemiologic data collected for the XFD outbreak
| Categories | Case numbers |
|---|---|
| Total infected cases during XFD outbreak | 368 |
| Key population | |
| Number of individuals in key population | 546 000 |
| Number of Infections identified from key population | 272 |
| Number of Infections identified via key population management | 224 |
| Close contacts | |
| Number of close contacts | 6607 |
| Number of close contacts with home-based quarantine | 1055 |
| Number of close contacts with centralized quarantine | 5552 |
| Number of infected close contacts | 84 |
| Number of infected cases identified via contact tracing | 42 |
| Expanded nucleic acid screening | |
| Number of people conducted nucleic acid screening | 10 878 289 |
| Number of Infected cases identified via expanded nucleic acid screening | 28 |
| Other methods | |
| Number of target population | 10 111 711 |
| Infected cases identified | 76 |
Fig. 1The illustration of the modified SEIR model. The model categorized the whole population into five subpopulations, susceptible (S), exposed and infected (not yet infectious) (E), infectious (I), infectious and isolated (IS) and removed (R). The IS group was further divided into two sub-populations according to the type of quarantine: those who were centralized quarantined (ISC) or home-based quarantined (ISH). E was further designated into a subpopulation K indicating key population to the XFD market, a subpopulation C indicating close contacts of confirmed cases, a subpopulation N representing the infections discovered by nucleic acid testing and a subpopulation O representing the infections identified by other methods
Results of scenario simulations on two outcomes: magnitude of transmission and endpoint of transmission
| Magnitude of transmission | Endpoint of transmission | ||||
|---|---|---|---|---|---|
| Scenarios simulated | Number of cases (95% | Relative increase fold (95% | Number of cases in target-population (95% | Relative increase fold (95% | Date of containment (Relative delay) |
| Timing of initiation comprehensive measures | |||||
| Reality: Delayed 0 days | 368 | - | 368 | July 10 | |
| Scenario 1: Delayed 3 days | 1104 (947–1261) | 3.0 (2.6–3.4) | 1104 (947–1261) | 3.0 (2.6–3.4) | August 10 (31 days) |
| Scenario 2: Delayed 7 days | 2768 (2360–3176) | 7.5 (6.4–8.6) | 2768 (2360–3176) | 7.5 (6.4–8.6) | August 29 (50 days) |
| Scenario 3: Delayed 14 days | 10,411 (8549–12,272) | 28.2 (23.2–33.3) | 10 411 (8549–12 272) | 28.2 (23.2–33.3) | September 25 (77 days) |
| Management of Key Population | |||||
| Reality: | 368 | - | 224 | July 10 | |
| Scenario 1: No quarantine | 1,969 (1,658–2,280) | 5.5 (4.5–6.2) | 1825 (1514–2136) | 8.2 (6.8–9.5) | September 21 (73 days) |
| Scenario 2: Quarantine high-medium risk | 640 (536–744) | 1.7 (1.5–2.0) | 496 (392–600) | 2.2 (1.8–2.7) | August 18 (39 days) |
| Quarantine of traced close contacts | |||||
| Reality: Centralized and home quarantine | 368 | 42 | July 10 | ||
| Scenario 1: No quarantine | 727 (609–844) | 2.0 (1.7–2.3) | 401 (283–518) | 9.5 (6.7–12.3) | August 23 (44 days) |
| Scenario 2: Centralized quarantine for all | 361 (330–392) | 1.0 (0.9–1.1) | 35 (4–66) | 0.8 (0.1–1.6) | July 5 (-5 days) |
| Scenario 3: Home quarantine for all | 382 (341–423) | 1.0 (0.9–1.2) | 56 (15–97) | 1.3 (0.3–2.3) | July 14 (4 days) |
| Expanded nucleic acid screening in the general population | |||||
| Reality: | 368 | 28 | |||
| Scenario 1: Accelerated 7 days | 332 (305–358) | 0.9 (0.8–1.0) | -8 (-35–18) | 0 | July 7 (-3 days) |
| Scenario 2: Accelerated 3 days | 352 (319–384) | 1.0 (0.9–1.0) | 12 (-21–44) | 0.4 (0–1.6) | July 8 (-2 days) |
| Scenario 3: Delayed 3 days | 429 (377 to 481) | 1.2 (1.0–1.3) | 89 (37–141) | 3.2 (1.3–5) | July 18 (8 days) |
| Scenario 4: Delayed 7 days | 487 (405 to 568) | 1.3 (1.1–1.5) | 147 (65–228) | 5.3 (2.3–8.1) | July 27 (17 days) |
| Scenario 5: No Nucleic Acid Screening | 603 (516 to 690) | 1.6 (1.4–1.8) | 263 (176–350) | 9.4 (6.3–12.5) | August 11 (32 days) |
CI Confidence interval
Fig. 2Scenario model simulation to assess the timing of intervention, management of key populations, contact tracing and expanded SARS CoV-2 Nucleic Acid screening. (a) and (a’) daily and cumulated total case number with the 3 day, 7 day, and 14 day delayed identification of XFD market as the
source of infection. (b) and (b’) daily and cumulated total case number simulated for management on the key population to the XFD market. (c) and (c’) daily and cumulated total case number simulated for the close contacts traced with different quarantine protocols. (d) and (d’) daily and cumulated total case number simulated for delayed or earlier expanded Nucleic acid screening on general population. Shading areas indicate 95% confidence intervals